Treasury yields rise again, weighing on stocks Oil trading above $90 US dollar flat Key EventsFutures on the Dow Jones, S&P 500, NASDAQ and Russell 2000 wavered in trading on...
Global shares set for largest 3-day gain since April Oil maintains gains but hits resistance Gold and the dollar slide Key EventsA strong start to earning season is helping traders...
Fed believes inflation will only be temporary Promises to warn ahead of any rate hikes Apple, Facebook report blowout earnings Key EventsYields on US Treasuries jumped along with...
Steepest 30Y:5Y yield curve in years Cyclical trade hits bump but reflation trade to resume Economically sensitive sectors in position to outperform Key EventsThe global rally in...
Will go below 40. One board is not improving the results or the outlook.
1
We therefore do not intend to pursue major acquisitions in the foreseeable future and will conduct a share buyback programme of up to €3 billion over the next two years.https://www.unilever.com/files/5b9872cf-337a-4bb4-9692-02a1b0a1b7fe/ir-q4-2021-full-announcement.pdf
1
a BUY signal on Market Mìracle advisor with target 48.67
0
this a long-term short
6
I dont understand the mentality of investing public. uniliver plc went down yesterday even though its bid was rejected by gsk. today again it is down by nearly 3% for no reason. in fact uniliver plc should have recovered all the price of 7% that occured yesterday.
0
Its because unilever will raise its bid.
2
no no
0
I think uniliver plc is hell bent to persue takeover of consumer business from GSK against the wishes of majority shareholders. that is why share is beaten down.
0
uniliver plc is victim of rumour mongers. when gsk has rejected the offer of uniliver plc where is the question of takeover of consumer division. shareholders are worried about higher consideration that may be offered by uniliver plc. under the circumstances it will be very difficult for uniliver plc to proceed further.
0
I think market has realised that uniliver plc will find it very difficult to acquire consumer division of GSK. That is why share is recovering. in that way hindustan uniliver is lucky to grab the consumer division of gsk in 2020 itself. Great salute to management of hindustan uniliver in india.
0
in my opinion gsk will not sell its consumer division at throw away price. it will be very difficult for uniliver plc to buy out gsk consumer division and at the end uniliver may drop the idea of buying gsk consumer division.